Market revenue in 2023 | USD 520.1 million |
Market revenue in 2030 | USD 837.7 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 19.02% in 2023. Horizon Databook has segmented the Japan peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The peripheral vascular devices market in Japan is expected to witness intense competition, characterized by the active participation of multinational enterprises and specialized entities striving for market dominance. Key players in the market include Cordis Corporation, Abbott, Boston Scientific Corporation, Cook, Medtronic, Terumo Corporation, and ASAHI INTECC CO., LTD., among others.
Some of the key players are involved in mergers & acquisitions, partnerships, and collaborations for product portfolio expansion, which is expected to contribute to market growth. For instance, in February 2023, Penumbra Inc. and Asahi Intecc Group entered into a definitive distribution agreement. This follows the initial basic agreement granting exclusive sales rights for a device for peripheral vascular thrombus aspiration, namely Indigo and Lightning system, in the market by Asahi Intecc J-sales, Inc.
It is noteworthy that Penumbra’s Peripheral Vascular Thrombus Aspiration system, specifically the Indigo system, received approval under the Japanese Pharmaceutical & Medical Device Act in April 2023. Despite achieving this regulatory milestone, there have been no substantial changes to the fundamental terms or content of the previously established basic agreement.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Japan peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account